Sentinel Lymph Node Auxiliary Clearance Trial
SENTINEL LYMPH NODE AUXILIARY CLEARANCE TRIAL
Being
launched Monday, 4 February in Auckland
The New Zealand Breast Cancer Foundation says this Australasian trial is an important development in the treatment of breast cancer of women.
"The role of sentinel lymph node biopsy as an indicator of the progression of invasive breast cancer has seen encouraging results in trials of over 9000 women in Europe and the United Kingdom;" says Dr Belinda Scott, chairperson of the Foundation's medical committee.
"It is vitally important that New Zealand surgeons have the same opportunity as their overseas counterparts to assess the safety and accuracy of this exciting surgical advance. The trial will also provide the opportunity for surgeons to develop a standard approach to this procedure throughout the country."
ends
Mana Mokopuna: Children’s Commissioner Welcomes New Youth Mental Health And Suicide Prevention Services In Te Tai Tokerau
New Zealand Kindergartens: 100-Years On - Investing In Teacher-Led, Quality Early Childhood Education Is Investing In Aotearoa’s Future
Dry July: Thousands Set To Go Alcohol Free This July As Cancer Diagnoses Continue To Rise Across Aotearoa
New Zealand College of Midwives: Celebrating Midwives Across Aotearoa This International Day Of The Midwife
PPTA Te Wehengarua: Building The Secondary Curriculum On Broken Drafts Is A Serious Risk
Whanganui Regional Museum: Whanganui Makers Bring Textile Traditions To Life During Symposium Weekend